Novavax, Inc. (Nasdaq: NVAX ) announced today new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax’s trivalent seasonal influenza Virus-like Particle (VLP) vaccine.
Novavax, Inc. (Nasdaq: NVAX ) announced today new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax’s trivalent seasonal influenza Virus-like Particle (VLP) vaccine.
Read the original:
NOVAVAX Reports Additional Positive Data From Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study In Healthy … (PharmaceuticalOnline)
ROCKVILLE, Md., Feb. 8 /PRNewswire-FirstCall/ — Novavax, Inc. (Nasdaq: NVAX) announced today new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax’s trivalent seasonal influenza Virus-like Particle (VLP) vaccine.
Read the original:
NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy … (redOrbit)
September 12th, 2009 WASHINGTON – Early results from various clinical trials of 2009 H1N1 influenza vaccines in healthy adults seem to be quite encouraging, say U.S. health experts. Asthmatic kids more vulnerable to H1N1 virus …
View original post here:
H1N1 in kids unpredictable but survivable with early care
Today’s research demonstrates that there is no need for healthy adults to have more that one dose of the H1N1 vaccine in order to be protected from the H1N1 f … Does the seasonal flu vaccine offer protection against H1N1 influenza?…
Continue reading here:
How effective is a single dose of H1N1 vaccine for adults?
Processing item: Immune System of Healthy Adults May Be Better Prepared Than Expected to Fight 2009 H1N1 Influenza Virus Dupecheck… Checking for duplicate title… Getting Item Link… Checking for blacklisted urls.
Visit link:
Four cases of H1N1 Tamiflu resistant (UPI) | H1N1 Alliance
FOR IMMEDIATE RELEASE Monday, Nov. 16, 2009 NIAID MEDIA AVAILABILITY Immune System of Healthy Adults May Be Better Prepared Than Expected to Fight 2009 H1N1 Influenza V irus http://www3. niaid.
View original post here:
Viral epitopes conservation
Seasonal Influenza What is it? An infection of the nose, throat and lungs that is caused by Influenza virus occurring usually in the winter months. Spreads from person to person. What are the symptoms?
Read the original here:
A Guide to Seasonal Flu and Novel H1N1 Flu
The H1N1 influenza virus is so new it’s not entirely understood, South Florida doctors say. It can be as mild as a cold or, rarely, so severe that blood pressure rapidly plummets, lungs collapse and kidneys fail, sometimes causing death. The observations come in light of a new report, published online Monday by the Journal of the American Medical Association , that says the most severe cases of H1N1 flu are happening to relatively young, healthy adults — even though modern therapies can sav
Link:
Study: Swine flu deadliest to healthy, relatively young adults
A recent study published in the New England Journal of Medicine (NEJM, 9/24/09) comparing the efficacy of live vs inactivated influenza vaccines given to adults during the 2007-2008 flu season, showed that the inactivated virus provided better protection against influenza A in healthy adults. The study involved 1952 healthy adults between 18 and 49 years of age who were randomly assigned to receive either the inactivated vaccine administered by injection or the live, attenuated (weakened)
Read more:
Inactivated Flu Vaccine vs Live, Attenuated Flu Vaccine – Which Gives Better Protection?